Wegovy pill version gets U.S. approval for weight loss
CBC News · New
CBC News
New
The U.S. Food and Drug Administration has approved a pill version of Wegovy, Novo Nordisk’s blockbuster weight loss drug, with the company claiming it offers a more convenient option than the previous injectable version.
Breakdown
- FDA approves first oral version of Wegovy weight loss drug
- Novo Nordisk says pill matches injectable's weight loss results 8s
- Daily pill expected to be cheaper and more appealing than injections 19s
- Novo Nordisk seeks Canadian approval; review could take up to 300 days 1m 4s
- Eli Lilly awaits U.S. approval for its own weight loss pill 1m 48s